Clinical Trials Logo

Fusion of Spine, Lumbar Region clinical trials

View clinical trials related to Fusion of Spine, Lumbar Region.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06002217 Recruiting - Clinical trials for Fusion of Spine, Lumbar Region

Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF)

TAP ALIF
Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The goal of this interventional study is to is to compare the effect of a tap block versus a placebo in patients undergoing anterior lumbar spine surgery. The main question it aims to answer : • whether tap block can reduce the need for postoperative pain medication Participants will be randomized into two groups and all postoperative pain medication will be recorded over 3 days. Researchers will compare tap block vs placebo to see if it reduces postoperative pain.

NCT ID: NCT05203588 Recruiting - Osteoporosis Clinical Trials

Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion

Start date: October 9, 2021
Phase: Phase 4
Study type: Interventional

Lumbar fusion is an accepted and effective technique for the treatment of lumbar degenerative disease. As the population ages, disability associated with spinal pathology and spinal surgery is rapidly increasing and there is a concomitant increase in prevalence of osteoporosis which is a detrimental factor for Lumbar fusion and instrumentation. Osteoporosis-related bone fragility is a primary reason for spinal fusion failure, implant fixation failure, and vertebral compression fractures above or below the fusion sites. Denosumab is a human monoclonal antibody against RANKL, it inhibits osteoclast mediated bone destruction and has been found to be effective in treating osteoporosis, including reducing bone turnover markers, increasing bone mineral density (BMD), and reducing fractures. But few studies focus on the effects of Denosumab on lumbar fusion. In this study, we include osteoporotic patients with lumbar degenerative disease who have had lumbar interbody fusion surgery. The patients were randomized to either treatment of Denosumab or no treatment. All these patients are followed at 3, 6, 9, 12 months postoperation. During these periods, we detect bone metabolism and bone fusion of these patients. Finally, we would report whether Denosumab can improve bone metabolism and promote bone fusion or not.

NCT ID: NCT03770338 Recruiting - Osteoporosis Clinical Trials

Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This project aims to investigate any difference of insertional torque strength for osteoporotic patients with preoperative 1-month teriparatide injections versus those without. The increased insertional torque of pedicle screws during surgery after only 1 month of teriparatide use has also been studied. However, the effect of teriparatide on vertebral body bone mineral density (BMD) prior to and after fusion surgery has not been studied. The effects on screw insertional torque has also not been studied via a randomized controlled trial method.

NCT ID: NCT01585337 Recruiting - Clinical trials for Fusion of Spine, Lumbar Region

Trunk Forward Ability in Patients With Lumbar Fusion

Start date: January 2012
Phase: N/A
Study type: Observational

The hypotheses of this study are as follows: 1. There is no significant muscle activity difference of each muscle in patients between pre and post operation. 2. There is no significant forward reach distance/average velocity difference in patients between pre and post operation. 3. There is no significant standard deviation of center of pressure (COP) along x axis, speed of COP along y axis during the task and COP path during the 3-sec holding phase difference in patients between pre and post operation. 4. There is no significant muscle activity difference between muscles on both sides at post operation.